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Abstract Changes in the skeletal system, which
include age-related bone and joint remodeling, can
potentially be used as a biomarker of biological
aging. The aim of the present study was to investigate
the extent and mode of inheritance of skeletal
biomarker of biological aging—osseographic score
(OSS), in a large sample of ethnically homogeneous
pedigrees. The investigated cohort comprised 359
Chuvashian families and included 787 men aged
18–89 years (mean 46.9) and 723 women aged
18–90 years (mean 48.5). The TOSS - transformed
OSS standardized in 5-year age groups for each sex,
was analyzed as a BA index. We evaluated familial
correlations and performed segregation analysis.
Results of our study suggest the familial aggregations
of TOSS variation in the Chuvashian pedigrees. In a
segregation analysis we found a signiﬁcant major
gene (MG) effect in the individual’s TOSS with a
dominant most parsimonious model (H
2 = 0.32).
Genetic factors (MG genotypes) explained 47% of
the residual OSS variance after age adjustment
and after including sex-genotype interaction, they
explained 52% of the residual variance. Results of
our study also indicated that the inherited difference
in the skeletal aging pattern in men lies mostly in the
rate of aging, but in women in the age of the onset of
the period of visible skeletal changes.
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Introduction
Biological age (BA) estimates the functional status of
an individual in reference to his or her chronological
peers on the basis of how well he or she functions in
comparison with others of the same chronological age
(Borkan and Norris 1986). Changes in the skeletal
system, which include age-related bone and joint
remodeling, can potentially be used as a biomarker of
BA. Skeletal aging measures are strongly correlated
with the status of the vital health systems (Gabriel
et al. 1999; Kiel et al. 2001, Kadam et al. 2004,
Kalichman et al. 2006b) and ultimately with survival
rates (Johansson et al. 1998; Haara et al. 2003). The
rate of degenerative changes in the skeleton
may reﬂect an individual’s biological resistance,
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or her chronological age. Therefore, age-related skeletal
changes can possibly be used as an index of BA.
Roentgenography is one of the common methods
used to assess health status and age-related changes in
bones and joints (Plato 1987; Plato et al. 1994).
Previously, Kobyliansky et al. (1995) reported an
osseographic scoring (OSS) system that uses hand
radiographstoassessskeletalaging.OSSisasynthetic
measure for assessing skeletal aging based on radio-
graphic features of the hand, combining both osteo-
porotic and osteoarthritic changes of hand bones and
joints. This system was originally suggested by
Pavlovsky(1987)andhasbeenusedinBAevaluations
inpopulationstudies(Kobylianskyetal.1995;Livshits
et al. 1996; Pavlovsky and Kobyliansky 1997).
Importantly, OSS has been shown to highly correlate
with chronological age in adults of different ethnic
groups (Karasik et al. 1999, Kalichman et al. 2002).
Accumulating research shows that single gene
changes in yeast, worms, and rodents can signiﬁ-
cantly alter life span (Kenyon et al. 1993; Kaeberlein
et al. 1999; Cheng et al. 2003; McBurney et al. 2003).
The observation that the ﬁrst-degree relatives of
human centenarians are both disease resistant and
have longer than average life spans implies a genetic
component to human longevity (Perls et al. 2002;
Atzmon et al. 2004). Current estimates based on twin
studies indicate that the human life span is 25%
heritable (McGue et al. 1993; Herskind et al. 1996;
Gudmundsson et al. 2000; Perls et al. 2002). Genetic
factors may also signiﬁcantly contribute to interindi-
vidual differences in BA (Karasik et al. 2004, 2005).
In variance component genetic analysis, performed in
Karasik’s study (2004), genetic factors explained
57% of the total variance of the BA index based on
OSS measurements.
The aim of our study was to investigate the extent
and mode of inheritance of a skeletal biomarker of
biological aging (OSS) in a large sample of ethnically
homogeneous pedigrees.
Materials and methods
Sample
The population sampled consisted of native Chuv-
ashians residing in numerous small villages in the
Chuvashia and Bashkartostan Autonomies of the
Russian Federation. The data were gathered in three
ﬁeld studies during August/September of 1994 (555
individuals), May/June of 1999 (715 individuals), and
September 2002 (240 individuals) by investigators
from the Department of Anatomy and Anthropology,
Sackler Faculty of Medicine, Tel Aviv University
(Israel), and the Institute of Anthropology, Moscow
University (Russia). The expeditions were part of a
Chuvashia Skeletal Aging Study (ChuSAS) project
whose main aim was to investigate the different
aspects of skeletal aging within the Chuvashia
population. All information collected and measure-
ments taken during all expeditions were done by
the same team of investigators. The investigated
cohort comprised 359 families and included 787 men
aged 18–89 years (mean 46.9) and 723 women aged
18–90 years (mean 48.5).
The Chuvashian population is characterized by a
stable family structure with traditional relationships.
For generations the Chuvashians have resided under
the same environmental conditions and have not been
exposed to an outside genetic ﬂow (El’chinova et al.
2003). In the present study, we collected data from
residents of a number of small villages (with a
predominant Chuvashian population) located in the
Volga region. A rural population is more homoge-
neous than urban in terms of ethnicity, occupation,
and physical activity. The study participants shared
similar living, economic, and professional conditions
with most individuals employed in agriculture or in
other occupations involving physical labor. Data
from 80% to 90% of the families (including all
family members who were living in the area at the
time of the expedition) were obtained. Since almost
every individual was related to one of the families,
we were able to collect data on up to 90% of the
population in each village. Data obtained from self-
completed questionnaires and conﬁrmed during the
interview included sex, age, age at menarche, age at
menopause and occupation. Menopause was deﬁned
as >12 months without menstruation. Age at last
menstruation was considered as menopausal age. In
order to minimize the possible recall bias, the
investigators excluded from the analyses all women
who had doubts about their age at menarche. The
anthropometrical measurements (weight, stature, etc.)
were also collected using standard methodology. In
the studied sample, there were no individuals with
628 Biogerontology (2007) 8:627–637
123known rheumatoid or psoriatic arthritis or users of
steroid medication. Subjects with post-traumatic hand
osteoarthritis were excluded from the study. All
procedures involved were consensual. The subjects
signed an informed consent form, and the entire
project was approved by the Helsinki Ethics Com-
mittee of Tel-Aviv University.
Additional information about the studied popula-
tion can be found in our previous publications: sex-
and age-related variations of the somatotype
(Kalichman and Kobyliansky 2006), reproductive
indices, such as age at menarche and at menopause
(Kalichman et al. 2006 a, 2007a) and sex- and age-
related variations of OSS (Kalichman et al. 2007b).
Hand radiographs
Single plain radiograms of both hands were taken
from each study participant in the postero-anterior
position with the X-ray source located 60 cm above,
using a standard radiographic technique, as described
in detail by Livshits et al. (1996). Hands were placed
on the same ﬁlm-containing plate to avoid any ﬁlm or
development variation. It was exposed for 5–10 s at
100–150 mA without intensifying screens at 50 kV.
OSS evaluation
An individual’s OSS was determined by the occur-
rence of the following: (a) bone proliferations (spurs),
including apiostoses (tufting of distal phalangeal
tuberosity), osteophytes, enthesophytes of the juxta-
articular area and at midshaft; (b) manifestations of
bone porosity, such as resorption of trabeculae,
development of lacuna (juxta-articular osteopenia)
and erosion of cortex; (c) loci of osteosclerosis,
deﬁned as enostosis and sclerotic nuclei; and sub-
chondral sclerosis; and (d) non-traumatic joint defor-
mities, deﬁned as narrowing of joint cavities and
periarticular bone corrosion (Kobyliansky et al. 1995;
Pavlovsky and Kobyliansky 1997; Karasik et al.
2005; Kalichman et al. 2007b). Phalanges of the 2nd
to 5th ﬁngers of the left hand were examined. The
ﬁrst ﬁnger (thumb) does not directly project in a
standard X-ray and was therefore not utilized. The
presence of a given feature, but not its level of
development, was documented for each OSS esti-
mate. The overall number of those skeletal aging
features was used as an OSS.
Each radiograph was read by an experienced
skeletal researcher according to the accepted protocol
of OSS evaluation. Ten X-rays were read and then re-
read by the investigator to estimate the intra-observer
reliability of the readings. All discrepancies were
reviewed for systematic errors. This exercise contin-
ued until the reliability was high (k > 0.8). After-
wards, the investigator read the remaining X-rays,
still blinded to patient identiﬁers. Before reading each
batch of X-rays one re-read 5 X-rays, which had been
previously read, to ‘‘calibrate’’ one’s readings to a
standard. The intra-observer reliability (kappa statis-
tics) was 0.82 (P < 0.01). The intraclass correlation
for the OSS was 0.92 (P < 0.01).
OSS reﬂects amount of skeletal changes occurring
stochastically during the life-span, and therefore it is
characterized by strong increase of trait variance
with age (Kalichman et al. 2007b and Fig. 1). It is
reasonable to assume that not the deviation of OSS
from the age-group mean, but only relative rate of
OSS accumulation with age can be inherited. Con-
sequently we constructed a trait using the standard-
ization in age-sex groups to equalize the means and
variances in the whole age range for both sexes. The
resulting trait, TOSS (transformed OSS) was further
analyzed. The biological meaning of this trait is the
relative position of individual (higher or lower than
average values of OSS) in his/her age-sex group
expressed in the units of SD speciﬁc for each group.
This accurately ﬁt the deﬁnition of BA as the
functional status of an individual in reference to his
or her chronological peers (Borkan and Norris 1986).
Statistical and genetic analysis
Prior to any other evaluations, the descriptive statis-
tics reﬂecting the basic characteristics of the studied
sample were computed in the whole sample and
within age groups of 5 years.
At the ﬁrst stage we computed familial (spouses,
parent-offspring and sib-sib) correlations between the
corresponding TOSS levels to examine the potential
genetic effect on the skeletal biomarker of BA.
The segregation analysis, as implemented in the
statistical package MAN (Malkin and Ginsburg
2003), was utilized in this study to test a mode of
inheritance of the skeletal biomarker of BA—TOSS.
Only individuals older than 29 were included in the
analysis, since the high prevalence of zero OSS
Biogerontology (2007) 8:627–637 629
123values in younger individuals make the standardiza-
tion approach unacceptable. More precisely, in two
5-year age groups younger than 30 years the distri-
bution of TOSS signiﬁcantly deviated from normal
(Chi-squarev
2-test for frequencies gave P <1 0
–6),
whereas in all older age groups did not (P > 0.01).
Only pedigrees having at least one measured pair of
relatives were included in the analysis. The mixed
model of inheritance (Morton and MacLean 1974;
Elston 1981; Lalouel 1983; Beaty 1997; Ginsburg
and Livshits 1999) estimates the effects of a potential
major gene and possible multifactorial effects, and is
described in detail in numerous publications, includ-
ing the aforementioned. The parameters that had been
estimated in the general model are deﬁned as follows:
p—the population frequency of allele A1 (assuming
diallelic gene locus); lgs—the average genotypic
value of individuals having genotype g and sex s
(g = 1, 2, and 3 corresponds to genotypes A1A1,
A1A2, and A2A2, respectively); r
2
g—the trait vari-
ance in individuals having the same major gene
genotype g, it estimates the trait variation resulting
from the effect of all possible environmental factors
and potential minor genes; sg—the transmission
probability parameter, which estimates the probabil-
ity that a parent of genotype g transmits allele A1 to
the next generation; q, b, and e are partial correlations
between the trait’s residuals adjusted for a major gene
effect, in spouses, parents/offspring, and the siblings,
respectively. A transmission probability test, de-
scribed by Ginsburg and Livshits (1999), was used
to estimate the signiﬁcance of the major gene (MG)
effect. A best-ﬁtting and most parsimonious Mende-
lian model was established after dropping all non-
signiﬁcant parameters.
Using the procedure implemented in the package
MAN (Malkin and Ginsburg 2003) and parameters
estimated for the most parsimonious model, we
determined the most likely MG genotype combina-
tion for each pedigree. We divided our sample into
groups according to sex and the determined individ-
ual genotype of putative BA-related MG for geno-
types having distinguishable genotypic values.
To analyze the age dependence of OSS, as a
primary (directly measured) BA-related index, in
groups of potentially different inherited BA, we used
the stochastic model, described in detail by Koby-
liansky et al. (1995). We estimated for each group the
following aging population parameters: t0—the ear-
liest age at which the ﬁrst signs of OSS can be found,
q—the individual probability of revealing the ﬁrst
signs of OSS changes per chronological time unit,
assuming an individual’s age  t0,a n dB—the
coefﬁcient characterizing the rate of OSS changes
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123per time unit (per year) after the process of aging has
started. Next, we built the age-dependent expectation
of the mean OSS level for each group according to
sex and predicted MG genotype. Using the likelihood
ratio test, we compared the extent of stochastic model
approximation, both accounting for the MG genotype
group and without it. Eventually we used ANOVA as
implemented in STATISTICA 6.0 (StatSoft 2000)t o
test the differences between parameters of female
organism development such as age at menarche and
age at menopause in MG genotype groups.
Results
Figure 1 shows the OSS mean values and SD in age
groups of 5 years. Up to age 45, men have higher
OSS scores than women. After age 45 OSS in women
was higher, compared with men and the sex differ-
ence in the OSS scores increases up to the end of the
age range. The OSS variance in age groups increases
rapidly up to age 50.
Familial correlations of TOSS (Table 1) showed
no signiﬁcant correlation for spouses, but parent-
offspring and sibling correlations were signiﬁcant.
This indicates the existence of a clear familial
aggregation of TOSS variation in the Chuvashian
pedigrees, which cannot be explained by pure com-
mon environmental effects. We investigated the
nature of TOSS inheritance later using segregation
analysis. Because of the method by which TOSS was
constructed (standardization within each sex-age
group), in the segregation model the sex effects were
not signiﬁcant. The other results are presented in
Table 2 and support the MG hypothesis regarding
trait inheritance. The most parsimonious Mendelian
model was dominant. The recessive allele with a
population frequency of 0.6 corresponded to rela-
tively slow aging. For the most parsimonious Men-
delian model, H
2 = 0.315; total proportion of TOSS
variance explained by the model was 0.349. Using
this model, we predicted the most likely MG
genotype combination for each pedigree included in
the analysis. Because of the dominant nature of the
most parsimonious model, we divided all individuals
into two groups with potentially different genotypic
values: (1) homozygous on allele A1 and (2) all the
rest. Using a stochastic model of aging (Kobyliansky
et al. 1995), we constructed the model of age
dependence of directly measured OSS for a whole
sample and for each predicted genotype group
separately with and without considering the effects
of sex. Table 3 presents the parameters of four
resulting models and a comparison between them.
According to the likelihood ratio test (LRT), Model
1, which included only the effect of age, has a
signiﬁcantly worse extent of approximation than both
Model 2, which included the effect of genotype-age,
and Model 3, which included the effect of sex-age.
The extent of approximation was signiﬁcantly higher
for the effect of genotype-age, which explained 47%
of the residual OSS variance after only adjustment for
age, and lower for the effect of sex-age (5%). Model
4, which includes all age-sex-genotype effects,
showed a signiﬁcantly higher extent of approximation
in comparison with other models and explained 52%
of the residual OSS variance after adjustment for age.
After adjustment for age and sex, the residual parent-
offspring correlation of OSS was signiﬁcant, but
became non-signiﬁcant after adjustment for the sex-
age-genotype.
Figure 2 shows a scatterplot of OSS-age for the
predicted genotypes in both sexes and the corre-
sponding curves of age-dependent OSS expectation
given by the stochastic model. For women in the
group of genotype A1A1 (with slow skeletal aging),
the age at menarche was signiﬁcantly higher
(P = 0.012) than in the group of genotypes A1A2 or
A2A2; the group mean difference was 0.45 year. The
difference in the age at menopause was in the same
direction, but not signiﬁcant for the whole sample.
Note that our sample includes women strongly
inﬂuenced by difﬁcult life conditions during World
War II. In these women the variance in the age at
menopause is increased in comparison with the
normal population. For women whose year of birth
 1937 (the normal part of the population), the age at
menopause was higher in group A1A1 than in other
group (P = 0.054); the group mean difference was
1.6 year.
Table 1 Familial correlations of TOSS
Relatives RN of pairs P
Spouses 0.08 333 0.15
Parent-offspring 0.12 755 0.002
Sib pairs 0.31 189 0.0008
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123To compare our ﬁndings with results of other
authors, we quantitatively analyzed the similarity of
differently constructed BA indices. The correlation
between the BA index proposed by Karasik et al.
(2004)a n dT O S Sw a s0 . 8 2i nt h eC h u v a s h i a n
population. The correlations between the BA index,
used by Livshits et al. (1996), versus the BA of
Karasik et al. (2004) and TOSS were estimated as
0.80 and 0.89, correspondingly. Though the resem-
blance of the indices may be inﬂuenced by population
type, the aforementioned BA indices are sufﬁciently
similar.
Discussion
In the present study, we evaluated the extent and
mode of inheritance of a skeletal biomarker of BA.
We constructed this biomarker (TOSS) to be maxi-
mally ﬁtted according to the BA deﬁnition; it reﬂects
the intensity of an individual’s skeletal changes in
relation to its coevals of the same sex, and the range
of the index does not depend on the age cohort.
We previously evaluated the association between
OSS, as an index of BA, with morbidity in a general
Chuvasha population (Kalichman et al. 2006b).
Statistically signiﬁcant association was found in
the present study between age-adjusted OSS and
rheumatic morbidity. Morbidities such as ischemic
heart disease, pulmonary diseases, traumatic brain
injuries and gynecological diseases also showed
differences between mean values of OSS in affected
vs. non-affected individuals. However, after correc-
tion for multiple testing, the statistical signiﬁcance
was insufﬁcient. The association between OSS and
diabetes mellitus was close to signiﬁcant (P = 0.07)
and we surmise that with a larger sample of
diabetic individuals, a clear-cut association will be
conﬁrmed.
It is well-established that genetic factors play an
important role in an individual’s BA (Karasik et al.
2005). Our ﬁnding suggests the familial aggregations
of TOSS variation within the Chuvashian pedigrees.
The evaluation of heritability of the skeletal biomar-
ker of BA in segregation analysis suggested the
existence of a MG effect with a most parsimonious
Table 2 Segregation analysis for TOSS (OSS standardized in age groups of 5 years for each sex)
Parameter Main models Restricted models
General Mendelian Equal s-s Arbitrary s-s Mendelian most parsimonious Equal s-s
12 3 4 5 6
P 0.600 0.628 0.252 0.558 0.598 ± 0.033 0.563
l1  0.727  0.724  1.080  0.758  0.729 ± 0.057  0.702
l2 0.481 0.525  0.329 0.380 0.429 ± 0.061 0.362
l3 0.362 0.385 0.383 0.380! 0.429! 0.362!
r1
2 0.299 0.325 0.074 0.255 0.303 ± 0.045 0.289
r2
2 1.074 0.988 0.504 1.165 1.067 ± 0.103 1.181
r3
2 0.205 0.232 1.049 0.255! 0.303! 0.289!
q 0.085 0.104 0.099 [0.000] [0.000] [0.000]
b 0.006  0.029 0.033 [0.000] [0.000] [0.000]
e 0.325 0.228 0.311 0.327 0.249 ± 0.067 0.327
s1 0.910 [1.000] 0.272 0.916 [1.000] 0.614
s2 0.632 [0.500] 0.272! 0.618 [0.500] 0.614!
s3 0.001 [0.000] 0.272! 0.020 [0.000] 0.614!
Log LH  1425.66  1428.27  1435.91  1427.29  1429.61  1440.51
v
2   5.22
NS (1) 20.5** (1) 1.63
NS (1) 4.64
NS (4) 26.44** (4)
NS—P > 0.05; ** P < 0.01
Number in parentheses in the v
2—row speciﬁes a comparative column
Constraints denotation: [ ]— parameter is ﬁxed to shown value; !— parameter is constrained to be equal to the parameter above in the
table
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123dominant model. A number of BA indices, based on
age-related skeletal changes, were previously pro-
posed and analyzed in different populations. Livshits
et al. (1996) analyzed the OSS measurement in the
Turkmenian population. They used the age-adjusted
OSS values as a BA index. This index showed a
Table 3 Parameters of stochastic aging models estimated for OSS data without grouping (1) and grouped according to predicted
genotype (2), sex (3), or both sex and predicted genotype (4)
Parameter All A1A1 A1A2 or A2A2
All t0 21.223 ± 0.933 21.705 ± 0.884 22.225 ± 1.179
q 0.118 ± 0.015 0.077 ± 0.010 0.217 ± 0.044
B 0.552 ± 0.004 0.518 ± 0.004 0.600 ± 0.004
TM 29.689 34.619 26.838
Model 1 (3 d.f.) Model 2 (6 d.f.)
R
2=0.838 R
2=0.915
Log LH= 3476.8 Log LH= 3065.5
– v
2= 822.6 (1)
Men t0 20.524 ± 1.231 21.573 ± 1.142 21.886 ± 1.683
q 0.127 ± 0.024 0.098 ± 0.014 0.233 ± 0.071
B 0.501 ± 0.005 0.449 ± 0.005 0.556 ± 0.005
TM 28.400 31.740 26.182
Women t0 22.078 ± 1.342 21.840 ± 1.169 22.623 ± 1.601
q 0.107 ± 0.019 0.057 ± 0.000 0.187 ± 0.046
B 0.617 ± 0.007 0.629 ± 0.008 0.657 ± 0.007
TM 31.400 39.373 27.979
Model 3 (6 d.f.) Model 4 (12 d.f.)
R
2=0.846 R
2=0.923
Log LH= 3443.3 Log LH= 3000.7
v
2= 67.0 (1) v
2= 952.2 (1); 129.6 (2); 885.2(3);
A1A1— genotype corresponding to lower values of TOSS in segregation analysis; t0— the minimal age at which initial bone changes
occurred in a group; q—the group probability that an individual will ﬁrst develop involutive bone change after age t0; B—the group
rate of aging (bone change) per time unit; TM—the expected mean age in a group in which the ﬁrst bone change occurred; number in
parentheses indicates the comparative model for LRT; all LRT values are signiﬁcant with P <1 0
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123signiﬁcant familial parent-offspring correlation of
0.1 ± 0.09, which is approximately the same as for
TOSS in our study (0.12). Nevertheless, in their
segregation analysis of the age-adjusted OSS, the
Mendelian model was rejected. A possible reason is
that a simple age adjustment does not equalize the
residual variance of OSS, which signiﬁcantly in-
creases with age. As a result, parents and offspring
received a BA index with different amplitude and this
difference probably prevented establishing MG inher-
itance in segregation analysis. Other phenotypes of
BA, as well, are characterized by substantial herita-
bility. Thus, functional age (other term for BA) has
been assessed by a general linear regression model of
many biomarkers in Minnesota twins (27–88 years
old). A subset of these biomarkers (mostly physio-
logical variables) identiﬁed by a factor analysis had
heritability of *59% (Finkel et al. 1995). Duggirala
et al. (2002) have reported that BA, measured
according to Uttley and Crawford (1994), had a
substantial genetic component (heritability ranging
from 0.27 ± 0.11 in one Mennonite geographical
subsample to 0.47 ± 0.18 in the other).
Karasik et al. (2004) studied a sample that
included 1,402 members of 288 pedigrees from the
Framingham Heart Study; the log-transformation was
used to reduce the growth of OSS variance with age.
A special BA index was constructed by adjusting the
individual’s age for log-transformed OSS with cubic
polynomial. The log-transformation automatically
excludes from the analysis all individuals with zero
OSS (note that for ages >30, the zero OSS value is
meaningful and denotes a low BA). For the resulting
trait, the genetic variance component analysis showed
that sex, height, the body mass index, and, in women,
menopausal status and estrogen use, jointly explained
approximately 6% of the total variance of BA index.
Genetic factors explained an additional 57%. The
genome search for this BA index revealed a number
of potential chromosomal regions in the two-point
analysis, but for multipoint, only the region on
chromosome 21 remained signiﬁcant.
The variance component analysis, used by Karasik
et al. (2004), a priori assumes a polygene mode of
inheritance. Our segregation analysis results conﬁrm
the ﬁndings about a signiﬁcant genetic effect and
furthermore suggest the existence of a MG effect in
an individual’s TOSS with a dominant most parsi-
monious model. The MG hypotheses may be, to some
extent, supported by the fact that in the multipoint
variance component linkage analysis by Karasik et al.
(2004) only one chromosomal region showed a
signiﬁcant LOD score >3 (likelihood ratio greater
than 10
3). We found that genetic factors (MG
genotypes) explained 47% of the residual OSS
variance after adjustment for age, and after including
the sex-genotype interaction, they explained 52% of
the residual variance. For TOSS the MG effect was
32%.
Additionally, we compared the age dependence of
OSS by directly measuring the individual’s skeletal
health index in predicted MG genotype groups.
Kobyliansky et al. (1995) proposed a two-stage
stochastic statistical model of the population aging
pattern for OSS. The implied stages are as follows:
(1) the period of life between birth and the apparent
onset of skeletal changes (t < ti), deﬁned as the latent
period, and (2) the period of visible changes begin-
ning after ti (which is not the same in different
individuals), when involutive changes occur contin-
uously throughout the remaining life. Applying this
model separately in predicted genotype groups, we
compared their aging features by means of model
parameters (t0, q, B). The earliest age of the ﬁrst
visible changes, t0, was almost the same in all sex-
genotype groups, about 22 years. The probability per
year of transition from the latent to the visible
changes period, q, was for genotype A1A1 about 1/3
of probability for other individuals. This was espe-
cially expressed for women and it results in greater
values of the average transition age TM (39.3 years in
A1A1-group and 31.7 for the others). The rate of
aging, B, was also signiﬁcantly different in the
predicted genotype groups, but this difference was
expressed more for men. Thus, we can conclude that
the inherited difference in the aging pattern lies in
men, mostly in the rate of aging, but in women, it is
in the age of onset of the period of visible changes.
An additional ﬁnding was that in the group A1A1
(slow aging), for women, the age at menarche was
signiﬁcantly greater (P = 0.012) than in the group
{A1A2 OR A2A2}. For women born after 1937 (those
whose maturation period was not inﬂuenced by WW
II or the subsequent rehabilitation period), the age at
menopause was also greater in the group A1A1
(P = 0.054). Thus, there is a positive relation between
the rate of sexual development and the rate of aging,
characterized by degenerative skeletal changes. The
634 Biogerontology (2007) 8:627–637
123rate of sexual development is positively associated
with intensity of normal metabolism, which also may
lead to accelerated aging. Early onset of menarche is
also known to be linked to other aging conditions
such as elevated blood pressure and glucose intoler-
ance, compared with later maturing girls, indepen-
dent of body composition (Remsberg et al. 2005).
The main molecular characteristic of aging is the
progressive accumulation of damages in macromol-
ecules that result on macro level in heterogeneity of
tissues and degenerative changes. Rattan (2006)
pointed out three major sources of this damage: (1)
reactive oxygen species (ROS) and free radicals
formed due to external inducers of damage (for
example ultra-violet rays), and as a consequence of
cellular metabolism; (2) nutritional glucose and its
metabolites, and their biochemical interactions with
ROS; and (3) spontaneous errors in biochemical
processes, such as DNA duplication, transcription,
post-transcriptional processing, translation, and post-
translational. Bessenyei et al. (2004) reviewed data
concerning SNPs associated with life span positioned
in a variety of genes regulating metabolic processes,
apoptosis, stress response (see also Singh et al. 2006)
and immune response. Several polymorphisms in ER-
alpha (estrogen receptor that are known to play
signiﬁcant role in skeletal development) were re-
ported to be associated with life span (Bessenyei et al.
2004) and with both osteoarthritis (Jin et al. 2004)
and osteoporosis (Albagha et al. 2005) related
phenotypes. The VDR (vitamin D receptor) gene is
also known to be associated with both types of
degenerative changes in certain skeletal sites (Uitter-
linden et al. 1997; Yue et al. 2005). A great number
of genes with signiﬁcant association signals were
cited in recent reviews of Loughlin (2005) (osteoar-
thritis) and Liu et al. (2006) (osteoporosis). de Boer
et al. (2002) described studies of mice with a
mutation in XPD, a gene encoding a DNA helicase
that functions in both repair and transcription. Mice
with mutation were found to exhibit many symptoms
of premature aging, including osteoporosis and
kyphosis, osteosclerosis, early greying, cachexia,
infertility, and reduced life-span. So OSS, the index
comprising various accumulated degenerative skele-
tal changes, despite to different molecular mecha-
nisms, which are involved in bone loss, cartilage loss
and other OSS components, may be under genetic
control of some polymorphic genes taking part in
DNA repair pathways, transcription and translation
control and/or some polymorphic genes controlling
intensity of normal metabolism, that inﬂuence the
rate of molecular damage (Kirkwood and Austad
2000). This supports the assumption that OSS as a
skeletal biomarker of BA can be used to evaluate the
organism’s general aging status.
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